Moderna Vaccine Close to FDA Approval

Imago via ZUMA

Fight disinformation. Get a daily recap of the facts that matter. Sign up for the free Mother Jones newsletter.

For some reason this doesn’t seem to be common knowledge, so it’s worth mentioning that the FDA’s vaccine advisory committee will be meeting again this Thursday to discuss emergency approval of a COVID-19 vaccine. This time it’s the Moderna vaccine, and there’s every reason to think they will recommend approval and the FDA will grant it. The United States purchased 100 million doses last summer and another 100 million doses a few days ago. Since the Moderna vaccine requires two shots, this is enough for 100 million people.

Between the Pfizer vaccine and the Moderna vaccine we will have enough to innoculate 150 million people, which will probably take us through mid-2021 at the rate we can reasonably expect the vaccines to be distributed.

This is good news, and there’s more: the Moderna vaccine appears to be slightly more effective than the Pfizer vaccine, and it can be stored in ordinary refrigerators for up to a month. This should make distribution much easier in more places than the Pfizer vaccine.

Between these two vaccines, as well as others coming down the pike, the US should be well supplied with enough vaccine to provide an innoculation to everyone who wants one over the next year or so. Ditto for other countries. It’s the beginning of the end.

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you'll agree is worth supporting.

payment methods

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you’ll agree is worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate